Evidence map›Paper›PMID 32770600›Full record

ArticleJournal of applied clinical medical physics2020

Voxel-based supervised machine learning of peripheral zone prostate cancer using noncontrast multiparametric MRI.

Neda Gholizadeh, John Simpson, Saadallah Ramadan, Jim Denham, Peter Lau, Sabbir Siddique, Jason Dowling, James Welsh, Stephan Chalup, Peter B Greer

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Neda GholizadehSchool of Mathematical and Physical Sciences, University of Newcastle, Callaghan, NSW, Australia.ORCID https://orcid.org/0000-0001-5524-8298
John SimpsonSchool of Mathematical and Physical Sciences, University of Newcastle, Callaghan, NSW, Australia.
Saadallah RamadanSchool of Health Sciences, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, 2308, Australia.
Jim DenhamRadiation Oncology Department, Calvary Mater Newcastle, Newcastle, NSW, Australia.
Peter LauHunter Medical Research Institute (HMRI) Imaging Centre, New Lambton Heights, NSW, Australia.
Sabbir SiddiqueRadiology Department, Calvary Mater Newcastle, Newcastle, NSW, Australia.
Jason DowlingCSIRO Australian e-Health Research Centre, Herston, Queensland, Australia.
James WelshSchool of Electrical Engineering and Computing, University of Newcastle, Callaghan, NSW, Australia.
Stephan ChalupSchool of Electrical Engineering and Computing, University of Newcastle, Callaghan, NSW, Australia.
Peter B GreerSchool of Mathematical and Physical Sciences, University of Newcastle, Callaghan, NSW, Australia.

Funding

Hunter Cancer Research Alliance G1301098Hunter Medical Research Institute
6 · The paper itself

Abstract

purposeThe aim of this study was to develop and assess the performance of supervised machine learning technique to classify magnetic resonance imaging (MRI) voxels as cancerous or noncancerous using noncontrast multiparametric MRI (mp-MRI), comprised of T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and advanced diffusion tensor imaging (DTI) parameters. MATERIALS AND

methodsIn this work, 191 radiomic features were extracted from mp-MRI from prostate cancer patients. A comprehensive set of support vector machine (SVM) models for T2WI and mp-MRI (T2WI + DWI, T2WI + DTI, and T2WI + DWI + DTI) were developed based on novel Bayesian parameters optimization method and validated using leave-one-patient-out approach to eliminate any possible overfitting. The diagnostic performance of each model was evaluated using the area under the receiver operating characteristic curve (AUROC). The average sensitivity, specificity, and accuracy of the models were evaluated using the test data set and the corresponding binary maps generated. Finally, the SVM plus sigmoid function of the models with the highest performance were used to produce cancer probability maps.

resultsThe T2WI + DWI + DTI models using the optimal feature subset achieved the best performance in prostate cancer detection, with the average AUROC , sensitivity, specificity, and accuracy of 0.93 ± 0.03, 0.85 ± 0.05, 0.82 ± 0.07, and 0.83 ± 0.04, respectively. The average diagnostic performance of T2WI + DTI models was slightly higher than T2WI + DWI models (+3.52%) using the optimal radiomic features.

conclusionsCombination of noncontrast mp-MRI (T2WI, DWI, and DTI) features with the framework of a supervised classification technique and Bayesian optimization method are able to differentiate cancer from noncancer voxels with high accuracy and without administration of contrast agent. The addition of cancer probability maps provides additional functionality for image interpretation, lesion heterogeneity evaluation, and treatment management.

Indexed as

Multiparametric Magnetic Resonance ImagingProstatic NeoplasmsBayes TheoremDiffusion Tensor ImagingHumansMagnetic Resonance ImagingMaleRetrospective StudiesSensitivity and SpecificitySupervised Machine Learningmachine learningmultiparametric MRIprobability mapprostate cancerradiomics

Identifiers

PMID32770600
PMCPMC7592985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.